[ad_1]
ABU DHABI, 21st October, 2022 (WAM) — The Ministry of Industry and Advanced Technology (MoIAT) announced today that a Memorandum of Understanding (MoU) worth AED 260 million (US$ 70.8 million) has been signed by major UAE pharmaceutical and medical device companies.
The partnership, signed in the presence of Sarah bint Youssef Al Amiri, Minister of State for Public Education and Advanced Technology, is in line with the National Strategy for Industry and Advanced Technology and the ICV scheme, which aims to attract investors and manufacturers into the UAE’s pharmaceutical and medical device industries, among others.
Under the partnership, PureHealth, one of the largest healthcare providers in the UAE and a member of the ministry’s national ICV scheme, will work with Abu Dhabi Medical Devices Company (ADMD), a subsidiary of the Abu Dhabi National Industrial Project, as Abu Dhabi The Ports Group and Abu Dhabi Polymers (Borouge) have established a Dh110 million medical supplies production line in Abu Dhabi. Under the MoU, Borouge will provide raw materials, while Abu Dhabi Ports Group will provide industrial sites at ICAD 1 for the production of medical syringes, drug delivery devices and blood collection tubes.
Under a separate memorandum of understanding, PureHealth and Gulf Pharma Industries (Julphar) will establish the first facility in the Middle East to manufacture insulin glargine, the first long-acting biological alternative to insulin, for the treatment of diabetes. The AED150 million manufacturing facility will be built in Ras Al Khaimah, which will allow the UAE to access insulin replacements at more competitive prices. It will also support exports to regional and global markets with growing demand for insulin substitutes.
The MoU between PureHealth and Abu Dhabi Medical Devices was signed by Farhan Malik, CEO of PureHealth Group; Mounir Haddad, CEO of Abu Dhabi Medical Devices; Abdullah Humaid Al Hamelli, Head of Abu Dhabi Port Industrial City and Free Zone and Borouge CEO Hazeem Sultan Al Suwaidi.
The second Memorandum of Understanding between PureHealth and Julphar was attended by Sheikh Saqr bin Humaid Al Qasimi, Chairman of the Board of Julphar. It was signed by Mr. Malik and Dr. Essam Mohamed, CEO of Julphar.
Two signing ceremonies were attended by Omar Al Suwaidi, Deputy Minister of Industry and Advanced Technology; Dr. Amin Al Amiri, Assistant Under-Secretary for Health Regulation, Ministry of Health and Prevention; Sameh Al Qubaisi, Director General of Economic Affairs, Department of Economic Development, Abu Dhabi; Industry and His Excellency Abdullah Al Shamsi, Assistant Under-Secretary for Industrial Development, Ministry of Advanced Technologies; and Omar Najm, Director, Office of Executive Affairs, Ministry of Health.
Success in the UAE.
The MoU follows the UAE Manufacturing Forum hosted by the Ministry of Industry and Advanced Technology in May. The forum highlighted industrial investment opportunities and identified products that could be produced locally, including the pharmaceutical and medical supplies industries.
This collaboration between major national companies attracts international investors and manufacturers working in priority areas. The Make it in the Emirates campaign is closely linked to the National Domestic Value (ICV) initiative, in which national companies help redirect government procurement spending towards the local economy.
Empower key industries.
Dr Sultan bin Ahmed Al Jaber, Minister of Industry and Advanced Technology, commented: “These partnerships are in line with our leadership’s directive to strengthen and stimulate industries, increase investment and support the UAE’s position as a global industrial hub. These partnerships are in line with our , and reflects the Ministry’s important role in the UAE Forum, which has identified more than 300 products that can be produced locally in priority sectors such as pharmaceuticals and medical devices.”
He said: “These partnerships will play an important role in boosting the economy through the national ICV programme. The ICV programme is one of 50 projects under the ministry to support economic growth. It improves supply chain resilience and encourages companies to produce in the UAE A quality product that can be exported worldwide.”
Dr. Al Jaber called on investors and industrialists from around the world to seize the investment opportunities offered by the UAE’s industrial growth. He urged businesses to take advantage of the “Make it in the Emirates” campaign and the UAE’s industrial investment climate. This environment includes competitive financing opportunities, business incubators, feasibility studies, strategic locations, world-class logistics infrastructure, the UAE’s global credibility, legislation protecting investors’ rights, and easy access to global markets.
For her part, Al Amiri said: “MoIAT is working under the direction of the UAE leadership to stimulate growth in priority areas such as medical technology and equipment. The capacity expansion that these partnerships will bring will help achieve self-sufficiency and increase global exports. .”
She added: “These agreements will strengthen local supply chains and help increase self-sufficiency in medicines and healthcare products. The MoUs also reflect the efforts of major national companies and institutions to integrate and collaborate, while increasing the number of citizens Opportunity to get quality jobs.”
Sheikh Saqr Bin Humaid Al Qasimi, Chairman of Julphar’s Board of Directors, said: “Julphar is focused on developing its capabilities to provide high-quality healthcare solutions to the Middle East and Africa. For over four months, we have established our reputation as an Emirati brand and have A successful model pioneered pharmaceutical manufacturing. Julphar leverages the technological and scientific capabilities that have positioned the UAE as a leader in the pharmaceutical industry. This new partnership helps increase production capacity and exports, in line with our strategy to open up new markets, While continuing to launch new products to compete in the global market.”
Abdullah Al Hameli, CEO of AD Ports Group Economic Cities and Free Zones, said: “AD Ports Group has partnered with leading UAE organisations from the public and private sectors to achieve the goals of the National Industrial and Advanced Technology Strategy and to position the UAE as a leader in strategic industries. Advanced Hub.
“These important agreements are in line with AD Ports Group’s commitment to drive economic diversification in line with the vision of our wise leadership. Khalifa Economic Zone, Abu Dhabi – KEZAD Group’s advanced infrastructure and services through its Life Sciences Centre, A successful track record in supporting the pharmaceutical industry. This allows us to sustain more growth, attract more manufacturers and increase pharmaceutical investment both regionally and globally.
“We are confident that this strategic collaboration between the UAE’s leading organisations will play a key role in strengthening and supporting the pharmaceutical and medical supply chain. KEZAD Group will continue to provide exceptional capabilities to ensure the success of this project and its partners Provides a competitive advantage and facilities.”
Hazeem Sultan Al Suwaidi, CEO of Borouge, said: “We are delighted to join this important strategic industrial partnership with the support of the Ministry of Industry and Advanced Technology. We will provide our partners with locally manufactured polyolefins that are Designed for the healthcare industry and improving people’s lives. This collaboration is part of Borouge’s ongoing efforts to support Make it in the Emirates, strengthening our position as a leading supplier of high-quality polyolefin solutions in the region. “
Dr Essam Mohamed, Chief Executive Officer of Gulf Pharmaceutical Industries Manufacturers (Julphar) said: “This MoU supports Julphar in the production of glargine and other medicines for the local and global market. As for the needs to cover the MENA region and other international countries, it will be agreed at a later date. Agreement. With 12 factories in Ras Al Khaimah, worth AED 150 million, and annual capacity to meet local and global market demand, Julphar will strengthen its position as a leading global manufacturer. The agreement represents the UAE, Julphar and A qualitative leap for the pharmaceutical industry, in line with the Make It in the Emirates initiative.”
Farhan Malik, Group CEO of PureHealth, commented: “At PureHealth, we are grateful to the Ministry of Industry and Advanced Technology for providing the company with a facility and a platform to create synergies that support the UAE’s national industrial agenda. “Make it in the Emirates” is a A key initiative that brings different sectors, including healthcare entities, on a common platform. Today’s MoU is a viable outcome of the follow-up to the “Make it in the Emirates” forum. At the forum, we at PureHealth worked with all Together with our industry colleagues, we are committed to MOIAT to enhance domestic value. We are committed and proud to participate in the ICV programme, an important long-term initiative to build a sustainable and prosperous future for the UAE. We believe that the ICV is not an optional program, but a must have program, and we urge all entities, especially those in the healthcare sector, to adopt the ICV program.
Malik added: “ICV is critical in the healthcare industry as the industry needs to be resilient in order to reduce its reliance on external factors. We are already in the midst of the fourth industrial revolution, which is the convergence of the biological, physical and digital worlds .Medtech, Biotech and Biopharma are at the heart of the Fourth Industrial Revolution. Supporting the local Pharma, Biotech and Medtech sectors is the best way to get the most out of this Industrial Revolution as we all focus on embracing Industry 4.0 With our commitment to the ICV programme, we look forward to celebrating many of these collaborations with other entities to play our role in supporting the growth and prosperity of the UAE’s economy.”
Mounir Haddad, CEO of Abu Dhabi Medical Devices (ADMD), said: “I would like to thank the Ministry of Industry and Advanced Technology for this initiative to support local manufacturing. In partnership with PureHealth, Abu Dhabi The partnership between Beacon and (Borouge) will allow us to expand our manufacturing footprint, increase our manufacturing capacity and add new products to our portfolio, providing high-quality products to the local health sector.”
He added: “We are delighted to be headquartered in Abu Dhabi, in addition to the importance of our location, we have the full support of the government, which allows us to easily enter the global market due to its Shipping convenience and a high reputation product in the UAE.”
Industrial growth.
Industry partnerships between Pure Health, Julphar, Abu Dhabi Medical Devices and other government and private entities are examples of industry integration and collaboration. Through these partnerships, companies will be able to source products locally, supporting supply chain localization and local suppliers. The ministry hopes they will pave the way for similar partnerships across sectors.
[ad_2]
Source link
